GlucoTrack, Inc.
GCTK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | -1.22 | -33.02 | -19.91 |
| FCF Yield | -7.57% | -2.26% | -0.29% | -0.10% |
| EV / EBITDA | -7.33 | -40.33 | -295.02 | -955.84 |
| Quality | ||||
| ROIC | 0.00% | -209.37% | -311.02% | -74.75% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.55 | 0.92 | 0.84 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | -92.04% | -75.82% | 1.17% | -6.19% |
| Safety | ||||
| Net Debt / EBITDA | 0.24 | 0.61 | 0.48 | 1.44 |
| Interest Coverage | -24.95 | 0.00 | -1,477.33 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -10,057.78 | -23,556.54 | -10,664.35 | -5,483.69 |